Back
Prelude Therapeutics Stock Price Chart
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
21
PRLD
Prelude Therapeutics
Last Price:
1.15
Seasonality Move:
21.44%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRLD is experiencing selling pressure, which indicates risk of future bearish movement.
Prelude Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.24 | Sell |
| 20-day SMA: | 1.5 | Sell |
| 50-day SMA: | 2.43 | Sell |
| 200-day SMA: | 3.88 | Sell |
| 8-day EMA: | 1.28 | Sell |
| 20-day EMA: | 1.52 | Sell |
| 50-day EMA: | 2.33 | Sell |
| 200-day EMA: | 3.61 | Sell |
Prelude Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.34 | Sell |
| Relative Strength Index (14 RSI): | 24.82 | Sell |
| Chaikin Money Flow: | -226175 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.3 - 1.9) | Sell |
| Bollinger Bands (100): | (2.02 - 5.4) | Sell |
Prelude Therapeutics Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Prelude Therapeutics Stock
Is Prelude Therapeutics Stock a Buy?
- Prelude Therapeutics share price is 1.20 while PRLD 8-day simple moving average is 1.24, which is a Sell signal.
- The stock price of PRLD is 1.20 while Prelude Therapeutics 20-day SMA is 1.50, which makes it a Sell.
- Prelude Therapeutics 50-day simple moving average is 2.43 while PRLD share price is 1.20, making it a Sell technically.
- PRLD stock price is 1.20 and Prelude Therapeutics 200-day simple moving average is 3.88, creating a Sell signal.
PRLD Technical Analysis vs Fundamental Analysis
Sell
21
Prelude Therapeutics (PRLD)
is a Sell
Is Prelude Therapeutics a Buy or a Sell?
-
Prelude Therapeutics stock is rated a Sell
The current Prelude Therapeutics [PRLD] share price is $1.20. The Score for PRLD is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
Prelude Therapeutics Stock Info
Market Cap:
65.77M
Price in USD:
1.20
Share Volume:
282.86K
Prelude Therapeutics 52-Week Range
52-Week High:
6.80
52-Week Low:
1.10
Sell
21
Prelude Therapeutics (PRLD)
is a Sell
Prelude Therapeutics Share Price Forecast
-
What is the Prelude Therapeutics stock price today?
The Prelude Therapeutics stock price is 1.20 USD today. -
Will PRLD stock go up or go down?
Prelude Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Prelude Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Prelude Therapeutics is overvalued.
Is Prelude Therapeutics Stock a Buy?
- Prelude Therapeutics share price is 1.20 while PRLD 8-day exponential moving average is 1.28, which is a Sell signal.
- The stock price of PRLD is 1.20 while Prelude Therapeutics 20-day EMA is 1.52, which makes it a Sell.
- Prelude Therapeutics 50-day exponential moving average is 2.33 while PRLD share price is 1.20, making it a Sell technically.
- PRLD stock price is 1.20 and Prelude Therapeutics 200-day simple moving average is 3.61, creating a Sell signal.
Fundamental Analysis of Prelude Therapeutics
Is Prelude Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.31 per share.
Technical Analysis of Prelude Therapeutics
Should I short Prelude Therapeutics stock?
- PRLD Moving Average Covergence Divergence (MACD) indicator is -0.34, suggesting Prelude Therapeutics is a Sell
- Prelude Therapeutics Relative Strength Index (RSI) is 24.82, which suggest Prelude Therapeutics is oversold
- The Bollinger Bands (25) for Prelude Therapeutics is (1.3 - 1.9), which suggest Prelude Therapeutics is a Sell
- The Bollinger Bands (100) for Prelude Therapeutics is (2.02 - 5.4), which suggest Prelude Therapeutics is a Sell
* Prelude Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.